Non-invasive Prenatal Testing (NIPT) Market Growth And Trends : Top Players Are GE Healthcare, Koninklijke Philips N.V., Illumina, Inc., Thermo Fisher Scientific, Inc.

Non-invasive prenatal testing is a DNA test on maternal blood to screen pregnancies for the most common fetal chromosome anomalies such as trisomy 21 that is Down syndrome, trisomy 18 Edwards syndrome and trisomy 13 Patau syndrome. Whereas NIPT can also determine the gender of the fetus and NIPT is highly reliable in over 99% of Down syndrome cases. The results of the NIPT screening can help doctor to decide the next steps, including whether to have a diagnostic test like chorionic villus sampling (CVS) or collected from the amniotic fluid or placenta, to make sure whether a baby has a chromosome abnormality. Non-invasive prenatal testing can be performed any time after 9 weeks into your pregnancy earlier than any other prenatal screening or diagnostic test.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/579

During non-invasive prenatal testing DNA from the mother and fetus is extracted from maternal blood sample and it is recommended for women who have risk factors for having a baby who has a chromosomal condition and this risk factor may include older maternal age or previously given birth to a baby who has Down syndrome, trisomy 13 or trisomy 18. Non-invasive prenatal testing is also recommended if a woman have an Rh negative blood type because if the fetus is Rh positive, mother might produce Rh antibodies after exposure to fetal red blood cells. This is not a concern during a first pregnancy, but during subsequent pregnancies. These factors are expected to provide major growth traction to the global non-invasive prenatal testing market.

Rise in number of women choosing late pregnancies is expected to fuel the growth of non-invasive prenatal testing market

The average maternal age nowadays is increased due to rise in number of working women so the risk of pregnancies has also increased which shows the growth in the market of NIPT. As a woman age the risk of having baby with Down syndrome increase but other factor also play a role, which include the number of existing siblings and how big is the gap between the child and his immediate preceding sibling. As according to Centers for Disease Control and Prevention in year 2016, Down syndrome continues to be the most common chromosomal disorder, as each year about 6000 babies were born with Down syndrome in the U.S.

Key players dominating the non-invasive prenatal testing market

The non-invasive prenatal testing market is driven by product launches and development strategies such as acquisition and collaboration by manufacturers. Recently Sequenom Inc. was acquired by LabCorp in January 2017. Other key players operating the market include GE Healthcare, Koninklijke Philips N.V., Illumina, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Pacific Biosciences of California, Inc., PerkinElmer, Inc., QIAGEN N.V., Agilent Technologies, Inc., and Beijing Genomics Institute.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/579

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.